Argonaut Manufacturing Services Inc. is a contract manufacturer specializing in life sciences, molecular diagnostics, and biopharmaceuticals. With a focus on every aspect of the manufacturing process, they offer support from product launch to scale-up to re-vitalization. Founded in 2016 and headquartered in the United States, Argonaut has recently received a significant $45.00M Venture Round investment from Telegraph Hill Partners and NewVale Capital on 05 March 2024. Their commitment to providing tailored solutions to their clients sets them apart in the biotechnology and manufacturing industries. For venture capitalists seeking investment opportunities in cutting-edge life science manufacturing, Argonaut presents a compelling prospect with its growing expertise and market potential.
No recent news or press coverage available for Argonaut Manufacturing Services Inc..